GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway
Cancer Biotherapy and Radiopharmaceuticals · 2024
DOI: 10.1089/cbr.2023.0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Shuangshuang Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Cell Proliferation. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
- Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China.
- School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
- Zhengzhou Railway Vocational and Technical College, Zhengzhou, China.
- Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Yixian Liu
Zitieren
APA
Yang, S., Liu, Y., Zhang, B., Li, J., Xu, F., Yu, M., Chen, Y., Li, C., Liu, T., Zhao, Y., Zhao, Q., & Zhang, J. (2024). GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0018
Vancouver
Yang S, Liu Y, Zhang B, Li J, Xu F, Yu M, et al. GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0018
BibTeX
@article{Yang2024,
author = {Yang, Shuangshuang and Liu, Yixian and Zhang, Bushi and Li, Jinxia and Xu, Fang and Yu, Mengdan and Chen, Ying and Li, Chenglong and Liu, Ting and Zhao, Ying and Zhao, Qianwei and Zhang, Jintao},
title = {GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2024},
doi = {10.1089/cbr.2023.0018}
}
EUVIMED